Cancer Diagnostics Market Analysis by Technology, Application & Region | Key Players Overview by Agilent Technologies, Inc., Becton Dickinson & Company, bioMeriux SA, Danaher Corporation, GE Healthcare, Hologic, Inc., Illumina, Inc., Philips Healthcare

The global cancer diagnostics market was valued at USD 134.16 billion in 2018. Rising prevalence of cancer and technological advancement in molecular diagnostics together drive the cancer diagnostics market. The up-to-date, complete product knowledge, end users, industry growth will drive the profitability and revenue. Cancer diagnostics market report studies the current state of the market to analyze the future opportunities and risks.

Get Research Insights at: https://www.adroitmarketresearch.com/contacts/request-sample/95

According to the latest statistics provided by American Cancer Society (ACS), the number of deaths pertaining to cancer is expected to increase from 9 million to 13 million at 44% increase in the time span from 2016 to 2030. Cancer is the second largest cause of death worldwide, oncologist strongly believe that early diagnosis can cure cancer and drastically reduce the mortality rate associated with cancer.

The global cancer diagnostics market is spread across North America, Europe, Asia Pacific, Latin America and Middle East & Africa regions. In the present scenario North America is leading the regional segment for global cancer diagnostics market. According to the latest research citings presented by American Cancer Society (ACS) in 2019, approximately 1.7 million new cancer cases are anticipated to be diagnosed. It is expected that in 2019, around 606,880 Americans will die due to cancer. The key factors driving the cancer diagnostics market growth in the region are domicile of market leaders such as Thermo Fisher Scientific, Inc., Hologic, Inc., Qiagen, GE Healthcare and Danaher Corporation. Europe trails behind in the second position owing to the rising prevalence of cancer and strategic collaboration between academic institutes and medical device manufacturers to launch new technology pertaining to cancer diagnostics. Asia Pacific is expected to exhibit rampant growth during the forecast period on account of constant rise in medical tourism and developing healthcare infrastructure.

Read more details at: https://www.adroitmarketresearch.com/industry-reports/cancer-diagnostics-market

The key players actively engaged in the production of cancer diagnostics are Agilent Technologies, Inc., Becton Dickinson & Company, bioMeriux SA, Danaher Corporation, GE Healthcare, Hologic, Inc., Illumina, Inc., Philips Healthcare, Qiagen, Siemens Healthineers and Thermo Fisher Scientific, Inc.
Key Segments of the cancer diagnostics market

By Technology, 2015-2025 (USD Billion)
o Imaging
o Molecular diagnostics
o Biopsy
o Others

By Application, 2015-2025 (USD Billion)
o Breast cancer
o Lung cancer
o Prostate cancer
o Colorectal cancer
o Skin cancer
o Others

Regional Overview, 2015-2025 (USD Billion)
o North America
o U.S.
o Canada
o Europe
o U.K.
o Germany
o Rest of Europe
o Asia Pacific
o China
o Japan
o Rest of Asia Pacific
o Latin America
o Brazil
o Mexico
o Rest of Latin America
o Middle East & Africa
o GCC
o Rest of MEA

Reasons for the study
o The purpose of the study is to give an exhaustive outlook of the global cancer diagnostics market
o The overall segmentation of the cancer diagnostics market, especially key segments such as technology and application is thoroughly studied. Molecular diagnostics and lung cancer are anticipated to be the fastest growing sub segment till 2025
o Rampant growth in medical tourism and developing healthcare infrastructure in the Asia Pacific regional segment will further drive the cancer diagnostics market growth
o Rising public health awareness and constant rise in disease diagnosis will further propel the cancer diagnostics market growth

Get discount on Purchase at: https://www.adroitmarketresearch.com/researchreport/purchase/95

About Us:

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market's size, key trends, participants and future outlook of an industry. We intend to become our clients' knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code- Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Ryan Johnson
Account Manager Global
3131 McKinney Ave Ste 600, Dallas,
TX 75204, U.S.A
Phone No.: USA: +1 972-362 -8199 / +91 9665341414

This release was published on openPR.